What is the official website of ASD Healthcare ?

The official website of ASD Healthcare is http://www.asdhealthcare.com.

What is ASD Healthcare's cybersecurity risk score?

ASD Healthcare has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has ASD Healthcare experienced?

According to Rankiteo, ASD Healthcare currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has ASD Healthcare been affected by any supply chain cyber incidents ?

According to Rankiteo, ASD Healthcare has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does ASD Healthcare have SOC 2 Type 1 certification ?

According to Rankiteo, ASD Healthcare is not certified under SOC 2 Type 1.

Does ASD Healthcare have SOC 2 Type 2 certification ?

According to Rankiteo, ASD Healthcare does not hold a SOC 2 Type 2 certification.

Does ASD Healthcare comply with GDPR ?

According to Rankiteo, ASD Healthcare is not listed as GDPR compliant.

Does ASD Healthcare have PCI DSS certification ?

According to Rankiteo, ASD Healthcare does not currently maintain PCI DSS compliance.

Does ASD Healthcare comply with HIPAA ?

According to Rankiteo, ASD Healthcare is not compliant with HIPAA regulations.

Does ASD Healthcare have ISO 27001 certification ?

According to Rankiteo,ASD Healthcare is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does ASD Healthcare operate in ?

ASD Healthcare operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does ASD Healthcare have ?

ASD Healthcare employs approximately 347 people worldwide.

Does ASD Healthcare own any subsidiaries ?

ASD Healthcare presently has no subsidiaries across any sectors.

How many LinkedIn followers does ASD Healthcare have ?

ASD Healthcare's official LinkedIn profile has approximately 3,479 followers.

What is the NAICS classification code for ASD Healthcare ?

ASD Healthcare is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does ASD Healthcare have a Crunchbase profile ?

No, ASD Healthcare does not have a profile on Crunchbase.

Does ASD Healthcare have a LinkedIn profile ?

Yes, ASD Healthcare maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/asd-healthcare.

How many cybersecurity incidents has ASD Healthcare experienced ?

As of July 3, 2026, Rankiteo reports that ASD Healthcare has experienced 11 cybersecurity incidents.

How many peer or competitor companies does ASD Healthcare have ?

ASD Healthcare has an estimated 5,700 peer or competitor companies worldwide.

What types of cybersecurity incidents has ASD Healthcare faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Cyber Attack and Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ASD Healthcare

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

ASD Healthcare Vendor Cyber Rating & Cyber Score

asdhealthcare.com

Add Your Compliance Badge

Known for specialty pharmaceutical distribution and innovative technology, ASD Healthcare provides 24/7 ordering to both pharmacies and health systems providers to ensure patients receive their needed medications. Our next day delivery and excellent True Blue customer service allows our customers to stay focused on taking care of their patients. Through strategic partnerships with GPOs and manufacturers, we offer over 2500 specialty pharmaceuticals including plasma derivatives, oncolytics, nephrology products, flu and more.

ASD Healthcare A.I CyberSecurity Scoring

Scoring History

ASD Healthcare

ASD Healthcare CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

ASD Healthcare

Breach

100

9/2025

AME476204709202...

Cencora

Breach

100

1/2025

INOCEN177580230...

ASD Healthcare

Breach

11/2024

WOR100072725

ASD Healthcare

Breach

100

9/2024

MWI630072625

ASD Healthcare

Breach

8/2024

AME345072925

ASD Healthcare

Breach

4/2024

AME425072825

ASD Healthcare

Breach

2/2024

MWI122072925

ASD Healthcare

Breach

2/2024

AME453224509302...

ASD Healthcare

Breach

2/2024

CEN270212709302...

ASD Healthcare

Cyber Attack

03/2023

ALL363723

ASD Healthcare

Breach

02/2023

AME62016223

Loading…

A.I.

ASD Healthcare Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ASD Healthcare

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for ASD Healthcare in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for ASD Healthcare in 2026.

Incident Types ASD Healthcare vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for ASD Healthcare in 2026.

Incident History - ASD Healthcare (X = Date, Y = Severity)

Loading…

SUBSIDIARY

ASD Healthcare Subsidiaries

ASD Healthcare

Pharmaceutical Manufacturing

Website: http://www.asdhealthcare.com

Company Size: 347

CencoraHospitals and Health Care

AmerisourceBergenHospitals and Health Care

Alliance HealthcarePharmaceutical Manufacturing

World CourierTransportation, Logistics, Supply Chain and Storage

MWI Animal HealthVeterinary Services

Innomar StrategiesPharmaceutical Manufacturing

ICSPharmaceutical Manufacturing

ION Oncology Practice NetworkPharmaceutical Manufacturing

American Health PackagingPharmaceutical Manufacturing

US BioservicesPharmaceutical Manufacturing

IntrinsiQ Specialty SolutionsPharmaceutical Manufacturing

Besse MedicalPharmaceutical Manufacturing

Triose, Inc.Transportation, Logistics, Supply Chain and Storage

Loading…

ASD Healthcare Similar Companies

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Loading…

NEWS

ASD Healthcare CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 27, 2026 08:00 AM

Tackling the growing cyber threat to Australian healthcare providers

Cyber attacks are escalating across healthcare, heightening pressure on hospitals to safeguard patient safety and keep clinical services...

Read Article

May 15, 2025 07:00 AM

Cybersecurity Concerns Rise for Australia's Infrastructure

Australian Signals Directorate says 11% of 1100 cyber incidents in targeted critical infrastructure, with phishing & credential compromise...

Read Article

May 13, 2025 07:00 AM

Australia faces rising cyberattacks targeting key infrastructure

Cyberattacks on Australia's critical infrastructure surged 50% to 143 in 2022–23, raising serious concerns over national security and...

Read Article

October 16, 2024 07:00 AM

Iranian Cyber Actors Access Critical Infrastructure Networks

FORT MEADE, Md. – The National Security Agency (NSA) is joining the Federal Bureau of Investigation (FBI) and the Cybersecurity and...

Read Article

August 27, 2024 07:00 AM

Australian Cyber Security Centre head Abigail Bradshaw to lead ASD

The head of the Australian Cyber Security Centre Abigail Bradshaw will take the reins at the Australian Signals Directorate (ASD) from early next month.

Read Article

August 05, 2024 07:00 AM

How the critical infrastructure act demands resilience measures

Healthcare, telecommunications and banking. Education, public sector and energy. In the past few years, headlines have highlighted the scale...

Read Article

January 10, 2024 08:00 AM

The ASD’s 2023 Cyber Threat Report reveals key trends of cybercrime in Australia

On 14 November 2023, the Australian Signals Directorate (ASD) published its 2022-2023 Annual Cyber Threat Report (Report).

Read Article

November 14, 2022 08:00 AM

Zoom successfully completes IRAP Security Assessment

The IRAP is an information security requirements program developed by the Australia Signals Directorate (ASD).

Read Article

June 18, 2018 07:00 AM

Breaking down the ASD’s “top four” strategies to mitigate cybersecurity incidents

The Australian Signals Directorate's (ASD) "Essential 8" is an excellent, tried-and-true security guide, designed for Federal government and...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-57100

SUMMARY

Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.

Published

Date2026-07-02

Updated

Date2026-07-02

RISK INFORMATION (Score: 9.9)

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

3.1

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57100

CVE-2026-54998

SUMMARY

Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.

Published

Date2026-07-02

Updated

Date2026-07-02

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-54998

CVE-2026-45499

SUMMARY

Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.

Published

Date2026-07-02

Updated

Date2026-07-02

RISK INFORMATION (Score: 9.9)

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

3.1

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-45499

CVE-2026-41106

SUMMARY

Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-07-02

Updated

Date2026-07-02

RISK INFORMATION (Score: 9.3)

cvss3

Base Score: 9.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N

Impact Score

5.8

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-41106

CVE-2026-26145

SUMMARY

Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.

Published

Date2026-07-02

Updated

Date2026-07-02

RISK INFORMATION (Score: 4.8)

cvss3

Base Score: 4.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

1.2

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-26145

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…